Under the patronage of His Excellency Dr. Mohamed Salim Al Olama, Undersecretary of the Ministry of Health & Avoidance in UAE, the Ministry of Health & Avoidance has authorized a Memorandum of Understanding (MoU) with Sanofi to launch comprehensive steps for the avoidance of non-communicable illness in the nation.

H.E. Dr. Hussein Abdul Rahman Al Rand, Assistant Undersecretary for the Ministry's Health Centers and Clinics Field and Public Health, and Jean-Paul Scheuer, Country Chair and General Manager, Gulf Countries, Sanofi, signed the MoU at the Ministry's headquarter in Dubai.

The joint campaign aims to establish programs that will certainly assist improve the skills of medical care professionals for far better disease management, apply national health recognition activities, and boost education and training on pharmaco-economics. The purpose of the MoU is to reinforce support for all the key stakeholders associated with the healthcare field consisting of, regulatory authorities, health providers (HCPs) and, patients and caregivers.

"The health care system in the UAE is taking every step to manage the occurrence of preventable illness amongst communities. Non-Communicable conditions such as diabetic issues and cardiovascular disease posture a risk to the health of the Emirati populace and people. The incidence of these problems could be significantly minimized if preventative and medicinal treatments are carried out properly. Collective public-private partnerships are vital to achieving our health care objectives and protecting the future of the nation. According to this, we are happy to have Sanofi's support in aiding us strengthen the healthcare framework in the UAE," stated H.E. Dr. Al Rand.

To supply an holistic approach, the effort includes tailored outreach activities created to efficiently inform various stakeholders and target groups for different condition areas.

H.E. Dr. Al Rand repeated the Ministry's commitment to supply outstanding health care solutions to the community according to international requirements of medical care and add better worth to its nationwide role and leadership. He pointed out that the growth of the health policy will certainly be based on clinical and sensible research as well as abide by the criteria and regulative structures to provide means to avoid and deal with diseases and epidemics. He added that non-communicable conditions are a danger to the health and wellness of the community; however, its occurrence can be dramatically minimized with proper and effective execution of preventive and therapeutic treatments. "Cooperation with the exclusive players have a key function in attaining our medical care goals and we are anticipating our collaboration with Sanofi to increase understanding and enlighten patients along with develop finest clinical methods," concluded H.E. Dr. Al Rand.

"At Sanofi, we are pleased to become part of the partnership with the UAE Ministry of Health and Prevention to even more our dedication in the direction of enhancing patient lives and adding to the development of healthy societies. Our initiatives are dedicated to increasing awareness among communities and support availability to top quality medical care services in UAE backed by scientific study." claimed Scheuer.

Public programs for communities will inform families on the advantages of adhering to a healthy way of living to stop persistent illness. Educational sessions will certainly be conducted for children and adolescents in schools. They will certainly receive interactive products focused on advertising the advantages of healthy diet regimen and physical activities, while cultivating a risk-free and encouraging school setting for children with diabetes mellitus in order to help handle their condition effectively.

In the sphere of communicable diseases, a 'Vaccine Expert Group' will combine vaccine leaders in the country to discuss unmet requirements and difficulties. This will be sustained by a sustained program to raise understanding on the relevance of immunization against conditions like flu among areas.

To motivate two-way communication in between clients, caregivers and the general public, an incorporated smart phone app will certainly be created to assist make the most of access to health care services.

The MoU likewise focuses on enhancing lab capacities and genetic assay experience by providing access to high-grade analysis testing for newborns, and free testing for clients with high risk of LSDs (Lysosomal Storage Conditions). The long-term plan involves establishing disease registries, collecting epidemiological information, and driving understanding campaigns and screening programs on rare conditions.